Today at 5pm: Revealing Our Big Prediction
Here is the latest financial fact sheet of ERIS LIFESCIENCES. For more details, see the ERIS LIFESCIENCES quarterly results and ERIS LIFESCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.2 |
No. of shares | m | 136.02 |
1 Week | % | -0.4 |
1 Month | % | -4.2 |
1 Year | % | 14.5 |
52 week H/L | Rs | 924.0/550.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ERIS LIFESCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 818 | 655 | 644 | 863 | 750 | |
Low | Rs | 572 | 341 | 367 | 577 | 551 | |
Sales per share (Unadj.) | Rs | 71.4 | 79.1 | 89.3 | 99.1 | 123.9 | |
Earnings per share (Unadj.) | Rs | 21.2 | 21.8 | 26.2 | 29.9 | 27.5 | |
Diluted earnings per share | Rs | 21.4 | 21.8 | 26.1 | 29.8 | 27.5 | |
Cash flow per share (Unadj.) | Rs | 23.8 | 25.5 | 29.3 | 34.6 | 36.1 | |
Dividends per share (Unadj.) | Rs | 0 | 2.87 | 5.50 | 6.01 | 7.35 | |
Adj. dividends per share | Rs | 0.00 | 2.86 | 5.49 | 6.01 | 7.35 | |
Avg Dividend yield | % | 0 | 0.6 | 1.1 | 0.8 | 1.1 | |
Book value per share (Unadj.) | Rs | 83.6 | 95.3 | 115.8 | 140.2 | 161.3 | |
Adj. book value per share | Rs | 84.5 | 95.1 | 115.6 | 140.2 | 161.2 | |
Shares outstanding (eoy) | m | 137.52 | 135.78 | 135.78 | 135.93 | 135.99 | |
Price / Sales ratio | x | 9.7 | 6.3 | 5.7 | 7.3 | 5.2 | |
Avg P/E ratio | x | 32.8 | 22.8 | 19.3 | 24.1 | 23.6 | |
P/CF ratio (eoy) | x | 29.2 | 19.5 | 17.2 | 20.8 | 18.0 | |
Price / Book Value ratio | x | 8.3 | 5.2 | 4.4 | 5.1 | 4.0 | |
Dividend payout | % | 0 | 13.1 | 21.0 | 20.1 | 26.7 | |
Avg Mkt Cap | Rs m | 95,518 | 67,649 | 68,637 | 97,846 | 88,446 | |
Total wages/salary | Rs m | 1,907 | 2,057 | 2,293 | 2,502 | 3,462 |
ERIS LIFESCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 9,822 | 10,741 | 12,119 | 13,470 | 16,851 | |
Other income | Rs m | 317 | 160 | 87 | 261 | 112 | |
Total revenues | Rs m | 10,139 | 10,901 | 12,206 | 13,731 | 16,963 | |
Gross profit | Rs m | 3,451 | 3,679 | 4,307 | 4,850 | 5,369 | |
Depreciation | Rs m | 364 | 503 | 430 | 647 | 1,171 | |
Interest | Rs m | 231 | 23 | 20 | 42 | 263 | |
Profit before tax | Rs m | 3,174 | 3,314 | 3,945 | 4,422 | 4,046 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 262 | 348 | 394 | 364 | 305 | |
Profit after tax | Rs m | 2,911 | 2,965 | 3,551 | 4,058 | 3,742 | |
Gross profit margin | % | 35.1 | 34.3 | 35.5 | 36.0 | 31.9 | |
Effective tax rate | % | 8.3 | 10.5 | 10.0 | 8.2 | 7.5 | |
Net profit margin | % | 29.6 | 27.6 | 29.3 | 30.1 | 22.2 |
ERIS LIFESCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 6,535 | 5,351 | 5,356 | 7,110 | 8,427 | |
Current liabilities | Rs m | 3,772 | 2,202 | 2,354 | 2,833 | 5,212 | |
Net working cap to sales | % | 28.1 | 29.3 | 24.8 | 31.7 | 19.1 | |
Current ratio | x | 1.7 | 2.4 | 2.3 | 2.5 | 1.6 | |
Inventory Days | Days | 141 | 33 | 109 | 151 | 15 | |
Debtors Days | Days | 31 | 53 | 42 | 44 | 63 | |
Net fixed assets | Rs m | 8,271 | 9,018 | 11,672 | 14,017 | 26,287 | |
Share capital | Rs m | 138 | 136 | 136 | 136 | 136 | |
"Free" reserves | Rs m | 11,356 | 12,799 | 15,589 | 18,928 | 21,796 | |
Net worth | Rs m | 11,493 | 12,935 | 15,724 | 19,064 | 21,932 | |
Long term debt | Rs m | 3 | 0 | 0 | 450 | 6,444 | |
Total assets | Rs m | 14,806 | 14,369 | 17,028 | 21,127 | 34,713 | |
Interest coverage | x | 14.8 | 145.3 | 200.7 | 105.8 | 16.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0.3 | |
Sales to assets ratio | x | 0.7 | 0.7 | 0.7 | 0.6 | 0.5 | |
Return on assets | % | 21.2 | 20.8 | 21.0 | 19.4 | 11.5 | |
Return on equity | % | 25.3 | 22.9 | 22.6 | 21.3 | 17.1 | |
Return on capital | % | 29.6 | 25.8 | 25.2 | 22.9 | 15.2 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 2.3 | 9.1 | 1.7 | 0.8 | 0.5 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 230 | 983 | 201 | 111 | 78 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 230 | 983 | 201 | 111 | 5,327 | |
Net fx | Rs m | -230 | -983 | -201 | -111 | -5,327 |
ERIS LIFESCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,230 | 2,712 | 3,754 | 3,783 | 2,917 | |
From Investments | Rs m | -51 | 1,232 | -3,234 | -3,196 | -9,821 | |
From Financial Activity | Rs m | -2,211 | -3,346 | -824 | -447 | 6,880 | |
Net Cashflow | Rs m | -31 | 598 | -304 | 140 | 52 |
Share Holding
Shareholding as on Jun 2023
|
Company Information
|
CHM: Amit Indubhushan Bakshi | COMP SEC: Milind Talegaonkar | YEAR OF INC: 2007 | BSE CODE: 540596 | FV (Rs): 1 | DIV YIELD (%): 0.9 |
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA SUN PHARMA PIRAMAL ENTERPRISES CIPLA LUPIN
Compare ERIS LIFESCIENCES With: AUROBINDO PHARMA SUN PHARMA PIRAMAL ENTERPRISES CIPLA LUPIN
After opening the day flat, Indian share pared early gains as the session progressed and ended lower.